by Jordana Choucair | Dec 20, 2021 | Opioid/Substance Use Disorders
A new HHS Office of the Inspector General report found that less than 16 percent of more than one million Medicare beneficiaries diagnosed with opioid use disorder in 2020 received medication to treat the condition. Furthermore, less than one third of those who...
by Jordana Choucair | Dec 17, 2021 | Opioid/Substance Use Disorders
A federal court judge has reversed the Purdue Pharma bankruptcy plan. A provision in the plan grants immunity to some of the Sacklers as well as hundreds of their associates from future lawsuits, even though — unlike Purdue — they did not file for bankruptcy...
by Jordana Choucair | Dec 9, 2021 | Opioid/Substance Use Disorders
AbbVie Inc.’s Allergan unit will pay up to $200 million to New York state and two counties to settle claims that it allowed opioid painkillers to overwhelm the region. State Attorney General Letitia James said that the funding will go toward opioid treatment,...
by Jordana Choucair | Dec 9, 2021 | Opioid/Substance Use Disorders
The Substance Abuse and Mental Health Services Administration announced it will distribute $30 million in grants to providers to boost harm reduction strategies. State and local governments, community-based organizations, and primary and behavioral health...
by Jordana Choucair | Dec 7, 2021 | Opioid/Substance Use Disorders
Representative Donald Norcross and Senator Ed Markey announced legislation Monday that would expand access to opioid medication. The Opioid Treatment Access Act targets restrictions on methadone. The bill specifically would make the easing of restrictions approved...
by Jordana Choucair | Nov 24, 2021 | Opioid/Substance Use Disorders
A jury in Ohio ruled that three major pharmaceutical chains bore responsibility for the opioid epidemic in two Ohio counties. The civil case, brought in federal court against CVS, Walmart, and Walgreens, marks the first time pharmacies have been found responsible in...
Recent Comments